Vertex PharmaceuticalsVRTX 
$474.16-1.48%24h
-1.48%24h
Global rank113
Market cap$122.19B
Change 7d-
YTD Performance17.08%
SP500 benchmarkUnderperform
P/E34.14
P/S12.38
Revenue$9.87B
Earnings$3.62B
Dividend yield-
Main Sector
Healthcare
Vertex Pharmaceuticals (VRTX) Cash on Hand
VRTX Cash on Hand in 2022: $11.22B
According to Vertex Pharmaceuticals latest financial reports the cash on hand of VRTX is $11.22B, an increase of 4.08% to 2022. At the end of 2022 company had $10.78B cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
VRTX Cash on Hand History from 2018 to 2023
-
Value:-
VRTX Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $11.22B | 4.08% |
| 2022 | $10.78B | 43.24% |
| 2021 | $7.52B | 13.01% |
| 2020 | $6.66B | 74.85% |
| 2019 | $3.81B | 20.20% |
| 2018 | $3.17B | - |
View the Top Cash on Hand Companies 
